CF
ALNY icon

Centaurus Financial’s Alnylam Pharmaceuticals ALNY Stock Holding History

Centaurus Financial’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-752
Closed -$151K – 743
2023
Q1 		$151K Buy
752
+11
+1% +$2.31K 0.01% 744
2022
Q4 		$176K Buy
741
+18
+2% +$3.84K 0.02% 643
2022
Q3 		$145K Buy
723
+23
+3% +$4.39K 0.01% 705
2022
Q2 		$102K Hold
700
– – 0.01% 800
2022
Q1 		$114K Hold
700
– – 0.01% 829
2021
Q4 		$119K Hold
700
– – 0.01% 839
2021
Q3 		$132K Hold
700
– – 0.01% 771
2021
Q2 		$119K Buy
+700
New +$103K 0.01% 811
2020
Q4 		– Sell
-720
Closed -$105K – 775
2020
Q3 		$105K Hold
720
– – 0.01% 612
2020
Q2 		$107K Buy
+720
New +$97.1K 0.02% 582
2018
Q3 		– Sell
-688
Closed -$68K – 582
2018
Q2 		$68K Buy
+688
New +$68.2K 0.01% 834

Other funds holding ALNY

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return